, Volume 70, Issue 6, pp 1575–1583 | Cite as

Hematopoietic stem cell and mesenchymal stem cell population size in bone marrow samples depends on patient’s age and harvesting technique

  • Katja Rebolj
  • Matija Veber
  • Matej Drobnič
  • Elvira MaličevEmail author
Original Article


Mesenchymal stem cells (MSCs) are heterogeneous population of cells with great potential for regenerative medicine. MSCs are relatively easy to expand in a cell culture, however determination of their concentration in harvested tissue is more complex and is not implemented as routine procedure. To identify MSCs collected from bone marrow we have used two combinations of cell markers (CD45/CD73+/CD90+/CD105+ and CD45/CD271+) and fibroblast colony-forming unit (CFU-F) assay. Further, in donors of various ages, mesenchymal stem cell concentration was compared with the result of CFU-F assay and with hematopoietic stem cell concentration, determined by a standardized flow cytometric assay. A positive correlation of MSC populations to the CFU-F numbers is observed, the population of the CD45/CD271+ cells correlates better with CFU-F numbers than the population of the CD45/CD73+/CD90+/CD105+ cells. The relationship between the hematopoietic CD45dim/CD34+ cell concentration and mesenchymal CFU-Fs or CD45/CD271+ cells shows a positive linear regression. An age-related quantitative reduction of hematopoietic CD45dim/CD34+, mesenchymal CD45/CD73+/CD90+/CD105+ and CD45/CD271+ stem cells, and CFU-F numbers were noted. Additionally, statistically significant higher CFU-F numbers were observed when bone marrow samples were harvested from three different sites from the anterior iliac crest instead of harvesting the same sample amount only from one site.


Mesenchymal stem cells CD271+ cells Bone marrow CFU-F assay Hematopoietic stem cells 



The work was supported by the Slovenian Research Agency (Grant No. P3-0371).


  1. Akamatsu H, Hasegawa S, Yamada T et al (2016) Age-related decrease in CD271(+) cells in human skin. J Dermatol 43:311–313CrossRefGoogle Scholar
  2. Alvarez-Viejo M, Menendez-Menendez Y, Blanco-Gelaz MA et al (2013) LNGFR (CD271) as marker to identify mesenchymal stem cells from different human sources: Umbilical cord blood, Wharton’s jelly and bone marrow. J Bone Marrow Res 1:132Google Scholar
  3. Ball LM, Bernardo ME, Roelofs H et al (2007) Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764–2767CrossRefGoogle Scholar
  4. Beane OS, Fonseca VC, Cooper LL, Koren G, Darling EM (2014) Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells. PLoS ONE 9:e115963CrossRefGoogle Scholar
  5. Boulais PE, Frenette PS (2015) Making sense of hematopoietic stem cell niches. Blood 125:2621–2629CrossRefGoogle Scholar
  6. Bühring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W (2007) Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262–271CrossRefGoogle Scholar
  7. Cuthbert R, Boxall SA, Tan HB, Giannoudis PV, McGonagle D, Jones E (2012) Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy 14:431–440CrossRefGoogle Scholar
  8. DiMarino AM, Caplan AI, Bonfield TL (2013) Mesenchymal stem cells in tissue repair. Front Immunol 4:210CrossRefGoogle Scholar
  9. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317CrossRefGoogle Scholar
  10. Eaves CJ (2015) Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125:2605–2613CrossRefGoogle Scholar
  11. Fennema EM, Renard AJ, Leusink A, van Blitterswijk CA, de Boer J (2009) The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta Orthop 80:618–626CrossRefGoogle Scholar
  12. Flores-Torales E, Orozco-Barocio A, Gonzalez-Ramella OR, Carrasco-Yalan A, Gazarian K, Cuneo-Pareto S (2010) The CD271 expression could be alone for establisher phenotypic marker in bone marrow derived mesenchymal stem cells. Folia Histochem Cytobiol 48:682–686PubMedGoogle Scholar
  13. Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87:1430–1437PubMedPubMedCentralGoogle Scholar
  14. Kebriaei P, Isola L, Bahceci E et al (2009) Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transpl 15:804–811CrossRefGoogle Scholar
  15. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR (1998) Single platform flow cytometric absolute CD34 + cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 34:61–70CrossRefGoogle Scholar
  16. Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18(2):307–316CrossRefGoogle Scholar
  17. Kresnik PK, Krasna M, Rozman P, Vrtovec B, Malicev E (2016) Collection and immunoselection of CD34+ cells: the impact of age, sex, and diabetes in patients with chronic heart failure. Transfusion 56:1792–1800CrossRefGoogle Scholar
  18. Kuçi S, Kuçi Z, Kreyenberg H et al (2010) CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica 95:651–659CrossRefGoogle Scholar
  19. Kuranda K, Vargaftig J, de la Rochere P et al (2011) Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 10:542–546CrossRefGoogle Scholar
  20. Maijenburg MW, Kleijer M, Vermeul K et al (2012) The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging. Haematologica 97:179–183CrossRefGoogle Scholar
  21. Maria AT, Maumus M, Le Quellec A, Jorgensen C, Noël D, Guilpain P (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allerg Immunol 52:234–259CrossRefGoogle Scholar
  22. McLain RF, Fleming JE, Boehm CA, Muschler GF (2005) Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 87:2655–2661PubMedPubMedCentralGoogle Scholar
  23. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ et al (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 108:20012–20017CrossRefGoogle Scholar
  24. Passweg JR, Halter J, Bucher C et al (2012) Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner. Swiss Med Wkly 142:w13696PubMedGoogle Scholar
  25. Prasad VK, Lucas KG, Kleiner GI et al (2010) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transpl 17(4):534–541CrossRefGoogle Scholar
  26. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783–791CrossRefGoogle Scholar
  27. Schündeln MM, Walde G, Basu O, Havers W, Kremens B (2014) Quantification of nucleated cells, CD34-positive cells and CFU-GM colonies in single bone marrow samples and bone marrow harvests derived from healthy children. Pediatr Hematol Oncol 31:340–348CrossRefGoogle Scholar
  28. Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129:163–173CrossRefGoogle Scholar
  29. Wu Y, Wang Z, Cao Y, Xu L, Li X, Liu P et al (2013) Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy. Ann Hematol 92:1675–1684CrossRefGoogle Scholar
  30. Yu JM, Wu X, Gimble J, Guan X, Freitas MA, Bunnell BA (2011) Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell 10:66–79CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Katja Rebolj
    • 1
  • Matija Veber
    • 2
  • Matej Drobnič
    • 3
  • Elvira Maličev
    • 1
    Email author
  1. 1.Blood Transfusion Centre of SloveniaLjubljanaSlovenia
  2. 2.Educell LtdTrzinSlovenia
  3. 3.Department of Orthopedic SurgeryUniversity Medical CentreLjubljanaSlovenia

Personalised recommendations